ARPI (androgen receptor pathway inhibitor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ARPI (androgen receptor pathway inhibitor), covering 2026-02-24 to 2026-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC [Phase 3]